Evidence map›Paper›PMID 35262978›Full record

ArticleVox sanguinis2022

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.

Arwa Z Al-Riyami, Thierry Burnouf, Erica M Wood, Dana V Devine, Adaeze Oreh, Torunn Oveland Apelseth, Ruchika Goel, Evan M Bloch, Karin van Den Berg, Mahrukh Getshen and 34 more

Abstract read
In one paragraph

Article in Vox sanguinis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
  4. Article
  5. Hyperimmune Globulins in COVID-19.Current topics in microbiology and immunology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Arwa Z Al-RiyamiDepartment of Haematology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.ORCID https://orcid.org/0000-0001-8649-0650
Thierry BurnoufGraduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-0507-9243
Erica M WoodTransfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Dana V DevineCentre for Innovation, Canadian Blood Services, Vancouver, British Columbia, Canada.
Adaeze OrehNational Blood Service Commission, Federal Ministry of Health, Abuja, Nigeria.ORCID https://orcid.org/0000-0001-9141-8215
Torunn Oveland ApelsethDepartment of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
Ruchika GoelDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-9653-9905
Evan M BlochDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-8181-9517
Karin van Den BergTransfusion Medicine and Technical Services Division, South African National Blood Service, Roodepoort, South Africa.
Mahrukh GetshenNational Blood Bank, Department of Pathology and Laboratory Medicine, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
Vernon LouwDivision of Clinical Haematology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Ai Leen AngBlood Services Group, Health Sciences Authority, Singapore, Singapore.ORCID https://orcid.org/0000-0002-7341-6862
Cheuk Kwong LeeHong Kong Red Cross Blood Transfusion Service, Hong Kong SAR.ORCID https://orcid.org/0000-0002-3939-564X
Naomi Rahimi-LeveneBlood Bank, Shamir Medical Center, Assaf Harofeh MC, Zerifin, Israel.ORCID https://orcid.org/0000-0003-3411-886X
Susan L StramerScientific Affairs, American Red Cross, Gaithersburg, Maryland, USA.
Ralph VassalloVitalant, Medical Affairs, Scottsdale, Arizona, USA.
Torsten J SchulzeGerman Red Cross Blood Service NSTOB, Springe, Germany.
Gopal Kumar PatidarDepartment of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.ORCID https://orcid.org/0000-0001-9681-3898
Hem Chandra PandeyDepartment of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-8180-0004
Rounak DubeyDepartment of Transfusion Medicine, NRI Academy of Medical Sciences, Andhra Pradesh, India.ORCID https://orcid.org/0000-0002-9467-5759
Maha BadawiHaematology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Salwa HindawiHaematology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0003-3804-5434
Abdullah MeshiDepartment of Blood Bank, King Fahd Central Hospital, Jazan, Saudi Arabia.
Tadashi MatsushitaNagoya University Hospital, Nagoya, Japan.
Enrico SorrentinoOzieri Transfusion Service, Antonio Segni Hospital, Ozieri, Italy.
Rada M Grubovic RastvorcevaInstitute for Transfusion Medicine of RNM, Skopje, North Macedonia.ORCID https://orcid.org/0000-0002-4885-3323
Renée BazinMedical Affairs and Innovation, Héma-Québec, Québec, Canada.
Marion VermeulenTransfusion Medicine and Technical Services Division, South African National Blood Service, Roodepoort, South Africa.ORCID https://orcid.org/0000-0003-4383-4526
Susan NahirniakTransfusion and Transplantation Medicine, Alberta Precision Laboratories, Calgary, Alberta, Canada.
Hamilton C TsangUniversity of Washington, Seattle, Washington, USA.
Hans VrielinkUnit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0001-7982-6718
Teguh TriyonoFaculty of Medicine, Universitas Gadjah Mada/Dr Sardjito Hospital, Yogyakarta, Indonesia.
Marcelo Addas-CarvalhoBlood Centre of UNICAMP, Campinas, Brazil.ORCID https://orcid.org/0000-0003-0178-6191
Ana HećimovićCroatian Institute of Transfusion Medicine, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-3632-0896
Oscar W TorresTransfusion Medicine Service, Hospital Churruca, Buenos Aires, Argentina.
Samclide M MutinduUnit of Transfusion Medicine, Centre Hospitalier Monkole, Kinshasa, Democratic Republic of Congo.
Jesper BengtssonDepartment of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Lund, Sweden.
Diego DominguezCentro Regional de Hemoterapia, Hospital Zonal Caleta Olivia, Caleta Olivia, Argentina.
Ahmed SayedahmedOmdurman Islamic University/National Central Laboratory, Khartoum, Sudan.ORCID https://orcid.org/0000-0002-3898-8814
Rozi Hanisa MusaClinical Transfusion, National Immunohematology Reference Laboratory, National Blood Centre, Kuala Lumpur, Malaysia.
Bipul GautamNepal Mediciti Hospital, Kathmandu, Nepal.
Eszter HerczenikISBT Central Office, Amsterdam, the Netherlands.
Cynthia So-OsmanUnit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-4151-2865
ISBT COVID-19 Convalescent Plasma Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe coronavirus disease 2019 (COVID-19) pandemic has impacted blood systems worldwide. Challenges included maintaining blood supplies and initiating the collection and use of COVID-19 convalescent plasma (CCP). Sharing information on the challenges can help improve blood collection and utilization. MATERIALS AND

methodsA survey questionnaire was distributed to International Society of Blood Transfusion members in 95 countries. We recorded respondents' demographic information, impacts on the blood supply, CCP collection and use, transfusion demands and operational challenges.

resultsEighty-two responses from 42 countries, including 24 low- and middle-income countries, were analysed. Participants worked in national (26.8%) and regional (26.8%) blood establishments and hospital-based (42.7%) institutions. CCP collection and transfusion were reported by 63% and 36.6% of respondents, respectively. Decreases in blood donations occurred in 70.6% of collecting facilities. Despite safety measures and recruitment strategies, donor fear and refusal of institutions to host blood drives were major contributing factors. Almost half of respondents working at transfusion medicine services were from large hospitals with over 10,000 red cell transfusions per year, and 76.8% of those hospitals experienced blood shortages. Practices varied in accepting donors for blood or CCP donations after a history of COVID-19 infection, CCP transfusion, or vaccination. Operational challenges included loss of staff, increased workloads and delays in reagent supplies. Almost half of the institutions modified their disaster plans during the pandemic.

conclusionThe challenges faced by blood systems during the COVID-19 pandemic highlight the need for guidance, harmonization, and strengthening of the preparedness and the capacity of blood systems against future infectious threats.

Indexed as

COVID-19PandemicsBlood BanksBlood DonorsBlood TransfusionCOVID-19 SerotherapyHumansImmunization, PassiveSurveys and Questionnairesblood supplyconvalescent plasmaCOVID-19pandemictransfusion

Identifiers

PMID35262978
PMCPMC9115426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.